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Key points:• Health-related quality of life (HRQoL) was measured in eight cohorts of older adultswith multimorbidities and various functional, cognitive, psychological or social disabilities.• 15D, a generic HRQoL predicted independently and significantly the 2-year survivalin the total sample.• However, 15D did not predict mortality in samples of spousal caregivers and lonelyolder adults.• In older populations suffering from psychological and social impairments such ascaregiver burden or loneliness HRQoL may not be the appropriate tool to detect those at risk.
Abstract
Background:Health-related quality of life (HRQoL) is associated with survival in older people withmultimorbidities and disabilities. However, older people  differ in their characteristics, and less isknown about whether HRQoL predicts survival in heterogeneous older population samplesdiffering in their functional, cognitive, psychological or social disabilities. The aim of this studywas to explore HRQoL in heterogeneous samples of older men and women, and to explore itsprognostic significance for mortality.
Methods:We analysed combined individual patient data from eight heterogeneous study samples all ofwhich were assessed with the same methods. We used 15D, a generic, comprehensive instrumentfor measuring HRQoL, which provides a single index in addition to a profile. Two-year mortalitywas retrieved from central registers.
Results:Health-related quality of life measurements with 15D were available for 3153 older adults. Themean HRQoL was highest among older businessmen (0.878) and lowest among nursing homeresidents (0.601). 15D predicted independently and significantly the 2-year survival in the totalsample (Hazard Ratio (HR)/SD 0.44, 95% CI 0.40 to 0.48)). However, 15D did not predictmortality in samples of spousal caregivers, lonely older adults and cardiovascular patients.
Conclusions: 15D captures health and disability factors associated with prognosis whereas inolder populations suffering from psychological and social impairments such as caregiver burdenor loneliness HRQoL may not reflect their health risks.
1. IntroductionAs functional impairments and losses concur with ageing, health-related quality of life (HRQoL)also declines as people age. On the other hand, ageing entails a number of positive dimensionsand coping mechanisms that may improve overall quality of life (QoL)(1, 2). The relationshipbetween HRQoL and aging is therefore complex.
There are several measurement scales available to measure HRQoL in older adults, with variousemphases on different dimensions of health (3).  Both disease specific and generic measuresexist, and based on the underlying concept of health and well-being,  they may include variousdimensions such as emotions, cognitive function, economic status, and intelligence. However, inthe heterogenous populations of older adults and it is still uncertain whether establishedmeasures address dimensions of HRQoL meaningful to older adults (2).
Heterogeneity in health including physical, mental, cognitive and social functioning increasesbetween individuals as they age. Older populations carry specific risks and burdens that maysignificantly affect their QoL and survival (4, 5).  Nevertheless, older people often evaluate theirQoL as being better than external evaluators do (2). In addition to diseases, disabilities andhealth-related factors, psychosocial, socioeconomic, environmental, and spiritual dimensionsmay be equally important for the QoL of older adults and thus may modify QoL measures (6). QoLin old age is often dependent amongst other factors on coping ability, attitudes, social activity andnetworks and life events, especially losses. Thus, the predictive value of HRQoL on health andsurvival may be less certain in older populations.
HRQoL has been shown to predict mortality in healthy populations (7), among seniors attendingprimary care clinics (8) and in a mixed population of older adults (9). However, this has not beenextended to other older people with cognitive deficits or in those with unique psychosocialcircumstances such as lonely older people and caregivers.
To better understand the importance of HRQoL in older adults, we assessed HRQoL and itsprognostic value in eight prospective samples of older adults, each with different proportions ofgenders, varying ages and comorbidity features, as well as having different levels of physical,cognitive, psychological, and social functioning.  Our aim was to compare HRQoL in these diversegroups and to determine whether HRQoL predicts mortality in older adults – both men andwomen – in various life circumstances.
2. Design and Methods
2.1 Study populationEight samples of older adults were studied for the association between HRQoL and mortality. Thesamples and the clinical processes in each study have been described in detail previously (10-17). The six randomised controlled trials (RCT) were originally designed to solve various clinicalor psychosocial problems related to older age. In addition, the set of studies included twoprospective cohort studies. The Helsinki Businessmen study (HBS) is an on-going cohort studyfollowing Helsinki based executives born between 1919 and 1934 (14, 17). The second cohortstudy is a random population sample, which was retrieved from the Finnish Population Register
in 2004 to serve as a comparison sample for the DEBATE study (10). The specific characteristicsof the studies are presented in Table 1.
Mortality data up to two years were retrieved from the Finnish Population Information System(Population Register Centre, Helsinki, Finland), which keeps a register of all Finnish citizens;thus, our determination of the vital status is virtually 100% complete.
2.2 Study proceduresThe same study group carried out the six RCTs and the two cohort studies; hence, similar studyprocedures were applied in all these studies. The information was gathered during a baselinevisit, which generally lasted about one hour and included interviews with the participant orcaregiver or both. Researchers collected demographic data, diagnoses, and current medications.Diagnoses and medications were confirmed from the medical records.
We assessed health-related quality of life of patients using the 15D instrument (18). The 15D is ageneric, comprehensive (15-dimensional), instrument for measuring HRQoL among adults. Thedimensions of the 15D are mobility, vision, hearing, breathing, sleeping, eating, speech, excretion,usual activities, mental function, discomfort and symptoms, depression, distress, vitality, andsexual activity.  It combines the advantages of a profile and a preference-based, single indexmeasure. A set of utility or preference weights is used to generate the 15D score (single indexnumber). The index varies between 0 (poorest HRQoL) and 1 (excellent HRQoL). The validity of15D has been assessed in several populations. In older populations including dementia patients itshows discriminant, criterion and prognostic validity (19).  Recently, it was studied in patients
with chronic pain, and compared with EQ-5D. Both instruments were valid and 15D somewhatmore sensitive. (3) Similarly, the validity was confirmed in a comparison with several otherHRQoL instruments in patients with rheumatoid arthritis (20). Usually the subject concerned fillsin the survey, but it may also be completed through an interview with the subject or their proxy.A difference of 0.015 in the 15D score between patient groups is considered minimally clinicallyimportant (21).
A number of other measures were also included to characterise the samples. These were theCharlson Comorbidity Index, which was calculated to assess the severity and prognostic value ofthe participants' burden of diseases (22), the Mini Mental State Examination (MMSE) (23) toassess cognition (in all samples except the population cohort), dementia diagnoses, self-ratedhealth, physical functioning according to “personal care” in Clinical Dementia Rating (24), and lifesatisfaction (“Are you satisfied with life?”(yes/no).
2.3 Ethical approvalLocal ethics committees approved the study protocols of each individual study. Written informedconsent was obtained from all participants or, in the event of cognitive impairment, from theparticipant’s closest proxy prior to study participation.
2.4 Statistical analysesIn the statistical analyses, all participants aged 64 or less were excluded from the samples tofocus solely on older individuals. To prevent individual subjects from participating twice andhaving samples dependent on each other, in cases where patients had been recruited to more
than one of our samples, they were excluded from the larger sample. Statistical significancebetween samples was evaluated by analysis of variance (ANOVA), the Kruskall-Wallis test or chi-square test. The normality of variables was evaluated by the Shapiro-Wilk W test. Correlationcoefficients were calculated by the Spearman method.
For each sample, the time-to-event analysis was based on the product limit (Kaplan-Meiermethod) estimate of the cumulative 2-year ‘mortality’ function. The Log-rank method was used toidentify mortality differences. The Cox proportional hazards model was used to estimate thepredictive value of baseline HRQoL for age and gender adjusted 2-year mortality for each sample.We also used hazard ratios to estimate how 2-year mortality increases for per 1-SD increase in15D.  Using for per 1-SD allows us to standardize varying mortality in these heterogeneoussamples and to make them comparable. The proportional hazards assumption was testedgraphically and by use of a statistical test based on the distribution of the Schoenfeld residuals.There was no evidence of violation of the proportional-hazards assumption in covariate-specificand global tests. We also combined comparable individual patient data from the original studies:baseline findings from seven trials and two prospective cohort studies, to give an overall hazardratio for mortality at 2 years. The caregivers’ sample was obtained from combining two dementiatrials (12, 14).
3. Results3.1 Characteristics of the subjectsThe baseline characteristics for the eight samples are presented in Table 1. The mean age of thesubjects in the samples varied from 75 to 85 years. In six studies, approximately two-thirds of the
subjects were women. The two exceptions were the HBS, which only included men, and the‘Dementia’ study, in which only 35% of subjects were women due to the fact that home-dwellingmale patients with dementia are often cared for by their wives.
Whereas nearly all nursing home residents were dependent in their ADLs, and two out of threepatients in the ‘Delirium’ trial and in the ‘Dementia’ studies needed assistance, only very lowproportions in the other samples needed help with their personal care. All those in the ‘Dementia’sample, 95% in the nursing home sample and 44% in the ‘Delirium’ sample suffered fromdementia, while other samples had very low numbers of dementia patients. The MMSE pointswere lowest among nursing home patients (mean 9.4), followed by patients with delirium (14.4)and home-dwelling patients with dementia (20.1) (Table 2).
The Charlson comorbidity index was highest in the DEBATE study (mean 3.7), followed bynursing home residents (2.7) and delirium patients (2.6). The same samples had also the highestmean number of drugs (Table 2).  On the other hand, the HBS men and the spousal caregivers hadthe lowest number of drugs and comorbidities. HBS participants had the highest proportion(96%) of those rating their health as good, followed by those in the population sample (88%),whereas only 49% of participants in the ‘Delirium’ trial rated their health as good.
Life satisfaction was highest in the population sample (94%), among HBS men (93%) and amongthe DEBATE participants (91%). The lowest proportions of those satisfied with their lives werefound among spousal caregivers (74%) and in the participants from the ‘Loneliness’ study (82%).
3.2 Health-related quality of life and the sample characteristics
Mean HRQoL as measured by the 15D in the total sample was 0.792 (SD 0.14). HRQoL washighest in the HBS study at 0.878 (SD 0.099). Generally, samples with the highest HRQoL by 15Dmeasurements were also those with higher life satisfaction (r=0.22; p<0.001) and fewercomorbidities (r=-0.38; p<0.001). Although fewer spousal caregivers were satisfied with life,their HRQoL was the second highest of all the samples (mean 0.844, SD 0.100).  In the populationsample, the mean 15D was also high (0.796, SD 0.132) as was HRQoL in the DEBATE study(0.794, SD 0.105), in patients with dementia (0.776, SD 0.117), and in the ‘Loneliness’  group(0.777, SD 0.117).
The lowest HRQoL on the other hand was observed among nursing home residents (mean 15D0.601, SD 0.118). Moreover, the participants from the ‘Delirium’ trial also had low mean 15Dindex scores (0.731, SD 0.115).
3.3 Health-related quality of life and mortalityDuring the two-year follow-up, a total of 386 deaths occurred, 231 in women and 155 in men.Mortality was highest among nursing home residents (42%/ 2 years) and among deliriumpatients (32%/2 years), and lowest among HBS men (4.2%) and spousal caregivers (4.3%) (seeFigure 1, Panel A).  There was a strong age-adjusted association between decreasing HRQoL andincreasing mortality in both men and women (Figure 2, Panel B).
HRQoL as measured by 15D significantly predicted the 2-year survival in the total sample ofparticipants of older age (Figure 3, Panel B). One SD (0.14) higher in the 15D index score from theweighted mean halved the mortality during the 2-year follow-up (HR 0.44, 95% CI 0.40 to 0.44,
p<0.001; adjusted by age and sex). While in all other samples the lower 15D predicted mortality,in the samples for spousal caregivers (HR 1.06, 95% CI 0.43 to 2.63, p=0.90, adjusted for age andsex), DEBATE participants (HR 0.68, 95% CI 0.42 to 1.09) and older adults in the ‘Loneliness’study (HR 0.94, 95% CI 0.47 to 1.87, p=0.85; adjusted for age and sex), HRQoL was notassociated with mortality.  Adjusting for the Charlson Comorbidity index did not alter thesignificant relationship between the 15D and mortality overall and in any subpopulation.
4. DiscussionPoor HRQoL as measured with the 15D predicted all-cause mortality during the 2-year follow-upin the combined sample of more than 3000 older individuals.  The association was independentof age, gender and also comorbidities. As well, HRQoL of life was independently associated withmortality at two years in most samples of older people including those with dementia, in nursinghomes and with delirium. According to our findings then, the 15D captures well health anddisability factors associated with poorer prognosis in clinical samples of older adults.
However, there were three samples where HRQoL did not predict mortality: the studies onspousal caregivers, the ‘Loneliness’ study, and the DEBATE study targeting older adults withconsiderable cardiovascular diseases. While this might be due to low statistical power, thesepopulations also differ from others in certain aspects that might affect the relationship betweenHRQoL and mortality.
A lack of an association between the 15D and mortality at 2 years in our study was seenparticularly in older populations where there were particular psychosocial impairments, i.e. in
the loneliness and in the caregiver samples where participants suffered from burden and strainof caregiving. Both situations are known to be associated with deteriorated health and mortality.The characteristics of both samples included independence in daily functioning and fairly lownumber of comorbidities. Although physically healthy a larger proportion of the individuals inthese samples showed low satisfaction of life than in other samples. Along with these twosamples the DEBATE sample was also very independent in their ADL activities. At the same timethey suffered from serious cardiovascular diseases exposing them to complications andmortality. Thus, HRQoL emphasizing functioning may not capture the health risks of this sample.
Previous studies have shown that caregivers of people with dementia suffer from both mentaland physical health problems (24). It has been suggested that caregivers experiencing strain havesignificantly elevated mortality risk even after adjustment for age, gender and comorbidities(25). Although the HRQoL measures often assess an individual’s depression, anxiety and physicalcapabilities, they may not capture the distress and burden caused as a result of caring forsomeone with a significant health condition. Monitoring caregivers’ non-traditional healthrisks—such as burden, stress, and strain—may better capture the relevant health risks in thisgroup of older adults. Findings in the ‘Loneliness’  group of our study also deviated from that ofthe other samples in that the 15D again did not predict two-year mortality in this group.Compared to the population sample, these participants had rather poor self-rated health (64%vs. 88%) and lower satisfaction with life (82% vs. 94%), although showing similar quality of lifeto the other groups as measured by 15D. Social and psychological pressures such as loss of closeones, disabilities, and lack of meaningful activities reduce life satisfaction among lonely (26, 27).There is indeed a growing body of evidence suggesting that loneliness is independently
associated with morbidity, cognitive decline and mortality (28, 29). However, the HRQoLmeasures may not to be able to detect such health risks adequately. Understanding andmeasuring those factors that impact the health of lonely people requires further study andadditional measurement scales.
The strengths of our study include the fact that our samples were prospective and carefullystudied using well-chosen clinical assessment methods. They represent the wide variety ofheterogenities in older populations. The parallel samples give us an opportunity to exploredifferent aspects of quality of life and other participant-important measures of older age. Apossible weakness of the study is that the samples had different inclusion and exclusion criteriaand we cannot claim the material represents the whole population. Another possible threat to thevalidity of our study is that we included both the intervention and control arms of therandomised controlled trials.  Nevertheless, the interventions did not have any effect on ouroutcome measure of mortality in the 2-year follow-up. Therefore, we believe that thegeneralisability of our results remains good in populations comparable to Finnish older adults.
ConclusionsIn conclusion our analysis revealed that overall, the 15D generic quality of life measure predictswell 2-year mortality in clinical samples of older adults independent of disease burden. Not onlyis the 15D therefore a valid tool for measuring HRQoL in older adults, it also is a valuableinstrument to capture health and disability associated with poor prognosis in most older people’ssamples. However, in older populations suffering from psychological and social impairments,such as those with caregiver burden or loneliness, the HRQoL 15D measure may not be the best
tool to detect those at risk, and exploration of additional emotional and social well-beingmeasures is therefore warranted.
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Legend to Figure 1.Mortality in heterogeneous samples of older people and its relationship with health-relatedquality of life according to 15D (Sintonen 2001). Panel A: 2-year mortality among men andwomen in heterogeneous samples of older adults. Panel B: 15D score and 2-year mortality in menand women in the combined samples. Panel C: Hazard Ratios with 95% confidence intervals formortality per SD of the 15D scores in eight samples and in combined data of the studies.
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Table 1. Descriptions of original samples of older people in the study
1 Strandberg et al. 2001; 2 Strandberg et al. 2016; 3 Laakkonen et al. 2012, Suominen et al. 2015; 4 Eloniemi-Sulkava et al. 2009, Suominen et al. 2015; 5 Pitkala et al. 2006; 6
Juola et al. 2014; 7 Pitkala et al. 2009; 8  Population sample used for comparison sample of ”DEBATE” study. 9 RCT=randomised, controlled trial
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Table 2. Baseline characteristics for the eight samples of older people according to clinical variables
DEBATE
(N=394)
 HBS
(N=733)
‘Dementia’
(N=214)
‘Spousal
caregivers’
(N=209)
‘Delirium’
(N=171)
‘Nursing
home’
(N=326)
‘Loneliness’
(N=208)
Population
sample
(N=901)
P-value8
Women, n (%) 257 (65.2) 0 75 (35.0) 135 (64.6) 125 (73.1) 228 (69.9) 156 (75.0) 677 (75.1) <0.001
Mean age, (SD) 80 (5) 77 (4) 77 (6) 75 (7) 84 (6) 84 (7) 80 (4) 85 (5) <0.001
Living at home, n (%) 394 (100) 702 (98.2) 214 (100) 209 (100) 133 (77.8) 0 (0) 193 (93.2) 886 (98.3) <0.001
Low education (<8 years), n % 182 (46.2) 0 (0) 65 (31.3) 53 (26.2) 87 (51.2) 213 (67.2) 101 (49.8) 436 (49.7) <0.001
Dependent in ADL-activities
(CDR1 ‘personal care’ >=1), n
(%)
0 (0) 50 (8.6) 134 (61.2) 2 (0.9) 114 (65.9) 318 (98.8) 0 (0) 54 (5.9) <0.001
Good self-rated health2, n (%) 265 (68.5) 702 (95.8) 158 (76.3) 157 (79.7) 75 (48.7) 189 (72.1) 128 (63.7) 774 (88.5) <0.001
Dementia3, n (%) 2 (0.5) 26 (3.6) 214 (100) 0 (0.0) 76 (44.4) 309 (95.1) 6 (2.9) .. <0.001
MMSE4, mean (SD) 26.3 (2.6) 28.4 (2.0) 20.1 (5.2) 27.5 (2.2) 14.4 (5.3) 9.4 (8.1) 27.0 (2.5) .. <0.001
Charlson5, mean (SD) 3.7 (1.8) 1.2 (1.4) 2.2 (1.4) 1.2 (1.4) 2.5 (1.9) 2.6 (1.7) 2.0 (1.6) 1.4 (1.6) <0.001
Number of drugs, mean (SD) 7.3 (3.4) 4.0 (3.1) 5.9 (2.9) 3.9 (2.7) 7.2 (3.7) 7.6 (3.0) 4.8 (2.9) 3.5 (2.4) <0.001
Satisfied with life, n (%) 353 (91.0) 673 (93.1) 1147 (87.0) 787 (73.6) .. 238 (85.3) 145 (82.4) 815 (94.4) <0.001
15D6, mean (SD) 0.79 (0.11) 0.88 (0.10) 0.78 (0.12) 0.84 (0.10) 0.73 (0.11) 0.60 (0.12) 0.78 (0.12) 0.78 (0.13) <0.001
2-year mortality, n (%) 28 (7.1) 31 (4.2) 11 (5.1) 9 (4.3) 54 (31.6) 138 (42.3) 12 (5.6) 103 (11.4) <0.001
1 CDR= Clinical dementia rating (Hughes et al. 1982); 2 Participants rated their health on the scale: very good/good/poor/very poor, with very good/good considered to good.
3 Dementia diagnoses were either self-reported (HBS, Spousal caregivers, Older people suffering from loneliness, Population sample), retrieved from medical records
(Nursing home residents) or confirmed with thorough diagnostics (DEBATE, home-dwelling people with dementia, DELIRIUM); 4 MMSE=Mini-mental State Examination
(Folstein et al. 1975); 5 Charlson comorbidity index (Charlson et al. 1987); 6 15D = generic measure for health-related quality-of-life (Sintonen 2001); 7 Only participants from
Eloniemi-Sulkava et al. 2009 study responded to this questions. 8 The differences between the cohorts were tested by X2 test for categorical variables, Kruskall Wallis and
ANOVA tests for continuous variables and Log Rank test for mortality.
